vs
Apellis Pharmaceuticals, Inc.（APLS）与Clear Secure, Inc.（YOU）财务数据对比。点击上方公司名可切换其他公司
Clear Secure, Inc.的季度营收约是Apellis Pharmaceuticals, Inc.的1.2倍（$240.8M vs $199.9M），Clear Secure, Inc.净利率更高（12.8% vs -29.5%，领先42.3%），Clear Secure, Inc.同比增速更快（16.7% vs -5.9%），Clear Secure, Inc.自由现金流更多（$187.4M vs $-14.3M），过去两年Clear Secure, Inc.的营收复合增速更高（16.0% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Clear Secure, Inc.是美国一家科技企业，主营生物识别旅行证件核验系统，其服务已覆盖部分大型机场与体育场馆。公司成立于2003年，2009年申请破产后停运，2012年重启运营，最终于2021年成功上市。
APLS vs YOU — 直观对比
营收规模更大
YOU
是对方的1.2倍
$199.9M
营收增速更快
YOU
高出22.7%
-5.9%
净利率更高
YOU
高出42.3%
-29.5%
自由现金流更多
YOU
多$201.7M
$-14.3M
两年增速更快
YOU
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $240.8M |
| 净利润 | $-59.0M | $30.8M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 22.4% |
| 净利率 | -29.5% | 12.8% |
| 营收同比 | -5.9% | 16.7% |
| 净利润同比 | -62.2% | -70.2% |
| 每股收益（稀释后） | $-0.40 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSYOU
| Q4 25 | $199.9M | $240.8M | ||
| Q3 25 | $458.6M | $229.2M | ||
| Q2 25 | $178.5M | $219.5M | ||
| Q1 25 | $166.8M | $211.4M | ||
| Q4 24 | $212.5M | $206.3M | ||
| Q3 24 | $196.8M | $198.4M | ||
| Q2 24 | $199.7M | $186.7M | ||
| Q1 24 | $172.3M | $179.0M |
净利润APLSYOU
| Q4 25 | $-59.0M | $30.8M | ||
| Q3 25 | $215.7M | $28.3M | ||
| Q2 25 | $-42.2M | $24.7M | ||
| Q1 25 | $-92.2M | $25.4M | ||
| Q4 24 | $-36.4M | $103.3M | ||
| Q3 24 | $-57.4M | $23.5M | ||
| Q2 24 | $-37.7M | $24.1M | ||
| Q1 24 | $-66.4M | $18.8M |
营业利润率APLSYOU
| Q4 25 | -25.6% | 22.4% | ||
| Q3 25 | 48.7% | 23.0% | ||
| Q2 25 | -18.6% | 19.4% | ||
| Q1 25 | -50.0% | 17.7% | ||
| Q4 24 | -12.3% | 16.5% | ||
| Q3 24 | -24.0% | 17.7% | ||
| Q2 24 | -14.7% | 16.2% | ||
| Q1 24 | -36.0% | 13.2% |
净利率APLSYOU
| Q4 25 | -29.5% | 12.8% | ||
| Q3 25 | 47.0% | 12.3% | ||
| Q2 25 | -23.6% | 11.3% | ||
| Q1 25 | -55.3% | 12.0% | ||
| Q4 24 | -17.1% | 50.1% | ||
| Q3 24 | -29.2% | 11.8% | ||
| Q2 24 | -18.9% | 12.9% | ||
| Q1 24 | -38.5% | 10.5% |
每股收益（稀释后）APLSYOU
| Q4 25 | $-0.40 | — | ||
| Q3 25 | $1.67 | — | ||
| Q2 25 | $-0.33 | — | ||
| Q1 25 | $-0.74 | — | ||
| Q4 24 | $-0.30 | — | ||
| Q3 24 | $-0.46 | — | ||
| Q2 24 | $-0.30 | — | ||
| Q1 24 | $-0.54 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $85.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $177.7M |
| 总资产 | $1.1B | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSYOU
| Q4 25 | $466.2M | $85.7M | ||
| Q3 25 | $479.2M | $75.8M | ||
| Q2 25 | $370.0M | $89.3M | ||
| Q1 25 | $358.4M | $87.6M | ||
| Q4 24 | $411.3M | $66.9M | ||
| Q3 24 | $396.9M | $32.9M | ||
| Q2 24 | $360.1M | $39.1M | ||
| Q1 24 | $325.9M | $64.1M |
总债务APLSYOU
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSYOU
| Q4 25 | $370.1M | $177.7M | ||
| Q3 25 | $401.2M | $148.6M | ||
| Q2 25 | $156.3M | $121.3M | ||
| Q1 25 | $164.2M | $116.7M | ||
| Q4 24 | $228.5M | $198.4M | ||
| Q3 24 | $237.1M | $129.0M | ||
| Q2 24 | $264.3M | $153.5M | ||
| Q1 24 | $266.7M | $165.9M |
总资产APLSYOU
| Q4 25 | $1.1B | $1.3B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $821.4M | $1.2B | ||
| Q1 25 | $807.3M | $1.1B | ||
| Q4 24 | $885.1M | $1.2B | ||
| Q3 24 | $901.9M | $858.6M | ||
| Q2 24 | $904.5M | $982.4M | ||
| Q1 24 | $831.9M | $1.0B |
负债/权益比APLSYOU
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $198.4M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $187.4M |
| 自由现金流率自由现金流/营收 | -7.1% | 77.8% |
| 资本支出强度资本支出/营收 | 0.1% | 4.6% |
| 现金转化率经营现金流/净利润 | — | 6.45× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $343.1M |
8季度趋势，按日历期对齐
经营现金流APLSYOU
| Q4 25 | $-14.2M | $198.4M | ||
| Q3 25 | $108.5M | $-47.3M | ||
| Q2 25 | $4.4M | $123.0M | ||
| Q1 25 | $-53.4M | $98.3M | ||
| Q4 24 | $19.4M | $136.6M | ||
| Q3 24 | $34.1M | $-35.9M | ||
| Q2 24 | $-8.3M | $114.6M | ||
| Q1 24 | $-133.0M | $80.3M |
自由现金流APLSYOU
| Q4 25 | $-14.3M | $187.4M | ||
| Q3 25 | $108.3M | $-53.5M | ||
| Q2 25 | $4.4M | $117.9M | ||
| Q1 25 | $-53.4M | $91.3M | ||
| Q4 24 | $19.3M | $133.9M | ||
| Q3 24 | — | $-37.9M | ||
| Q2 24 | $-8.4M | $110.1M | ||
| Q1 24 | $-133.3M | $77.6M |
自由现金流率APLSYOU
| Q4 25 | -7.1% | 77.8% | ||
| Q3 25 | 23.6% | -23.3% | ||
| Q2 25 | 2.5% | 53.7% | ||
| Q1 25 | -32.0% | 43.2% | ||
| Q4 24 | 9.1% | 64.9% | ||
| Q3 24 | — | -19.1% | ||
| Q2 24 | -4.2% | 59.0% | ||
| Q1 24 | -77.3% | 43.3% |
资本支出强度APLSYOU
| Q4 25 | 0.1% | 4.6% | ||
| Q3 25 | 0.0% | 2.7% | ||
| Q2 25 | 0.0% | 2.3% | ||
| Q1 25 | 0.0% | 3.4% | ||
| Q4 24 | 0.0% | 1.3% | ||
| Q3 24 | 0.0% | 1.0% | ||
| Q2 24 | 0.0% | 2.4% | ||
| Q1 24 | 0.2% | 1.6% |
现金转化率APLSYOU
| Q4 25 | — | 6.45× | ||
| Q3 25 | 0.50× | -1.67× | ||
| Q2 25 | — | 4.97× | ||
| Q1 25 | — | 3.87× | ||
| Q4 24 | — | 1.32× | ||
| Q3 24 | — | -1.53× | ||
| Q2 24 | — | 4.75× | ||
| Q1 24 | — | 4.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
YOU
暂无分部数据
